The potential of low-dose camptothecin to reduce perioperative dexamethasone-promoted tumorigenicity in glioblastoma

Marchon, Florian; Lippuner, Christoph; Jaggi, Stephanie; Stüber, Frank; Lüdi, Markus (October 2018). The potential of low-dose camptothecin to reduce perioperative dexamethasone-promoted tumorigenicity in glioblastoma. In: American Society of Anesthesiology annual meeting/session Clinical Neurosciences. San Francisco. October 13-17 2018.

[img] Text (Presentation of abstract)
Marchon_abstract_camptothecin_ASA meeting_Luedi presenter_2018.pdf - Presentation
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (489kB)

Item Type:

Conference or Workshop Item (Poster)

Division/Institute:

04 Faculty of Medicine > Department of Intensive Care, Emergency Medicine and Anaesthesiology (DINA) > Clinic and Policlinic for Anaesthesiology and Pain Therapy
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Anästhesiologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Anästhesiologie

UniBE Contributor:

Marchon, Florian; Lippuner, Christoph; Jaggi, Stephanie; Stüber, Frank and Lüdi, Markus

Subjects:

600 Technology > 610 Medicine & health

Language:

English

Submitter:

Jeannie Wurz

Date Deposited:

26 Nov 2018 10:29

Last Modified:

26 Nov 2018 10:29

Related URLs:

Additional Information:

The abstract was presented by Markus Lüdi

BORIS DOI:

10.7892/boris.121555

URI:

https://boris.unibe.ch/id/eprint/121555

Actions (login required)

Edit item Edit item
Provide Feedback